Latest Cancer immunotherapy Stories
Because cancer cells grow very quickly, chemotherapy is designed to target cells whose numbers grow rapidly.
Rather than stimulating immune cells to more effectively battle cancerous tumors, treatment with the protein interleukin-12 (IL-12) has the opposite effect, driving these intracellular fighters to exhaustion, a Mayo Clinic study has found.
Researchers at Fox Chase Cancer Center in Philadelphia have found that a protein associated with other cancers appears to also be important in head and neck cancer, and may consequently serve as a good target for new treatments.
Human tumors transplanted into laboratory mice disappeared or shrank when scientists treated the animals with a single antibody.
The utility of a naturally occurring protein given, sometimes to great effect, as a drug to treat advanced cancers is limited by the severe side effects it sometimes causes.
- A political dynamiter.